The Veterinary Antimicrobial Susceptibility Market size was valued at USD 1019 million in 2024 and is anticipated to reach USD 1553.2 million by 2032, at a CAGR of 5.41% during the forecast period (2024-2032).
Key drivers of the market include the rising prevalence of zoonotic diseases, the increasing demand for high-quality animal-based products, and advancements in veterinary diagnostics. Moreover, the push for better regulatory standards and protocols in animal health, along with the increased focus on preventive measures rather than reactive treatments, is significantly influencing market growth. The growing adoption of rapid diagnostic tests to identify antimicrobial susceptibility is also contributing to the market’s expansion, improving treatment outcomes and controlling the spread of resistant pathogens. Additionally, growing investments in veterinary research and development are accelerating the availability of innovative antimicrobial susceptibility testing solutions.
Regionally, North America leads the market, driven by advanced healthcare infrastructure, strong regulatory frameworks, and rising awareness about the impact of AMR. The Asia-Pacific region is expected to witness the highest growth, owing to increasing livestock populations, growing economies, and improving healthcare systems in emerging markets like China and India. Europe is also a significant market, focusing on stringent regulations regarding antimicrobial usage in veterinary care.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
The Veterinary Antimicrobial Susceptibility Market is valued at USD 1,019 million in 2024 and is expected to reach USD 1,553.2 million by 2032, growing at a CAGR of 5.41% during the forecast period.
Rising zoonotic diseases significantly contribute to the market, as the need for effective antimicrobial treatments increases to prevent infections transmitted from animals to humans.
The increasing demand for high-quality animal-based products continues to drive market growth, with veterinary antimicrobial susceptibility testing ensuring animal health and maintaining the quality of food products.
Advancements in veterinary diagnostics, such as rapid diagnostic tools, help reduce the use of ineffective antibiotics, thereby improving treatment outcomes and limiting the spread of resistant pathogens.
The growing focus on preventive measures in veterinary care, including vaccination and early identification of antimicrobial resistance, is reshaping practices and boosting the demand for antimicrobial susceptibility testing.
North America dominates the market, holding a 40% share, driven by advanced healthcare infrastructure, strong regulatory frameworks, and high awareness of antimicrobial resistance.
The Asia-Pacific region, holding 20% of the market share, is witnessing rapid growth due to rising livestock populations, expanding economies, and improving veterinary care infrastructure in emerging markets.
Market Drivers:
Rising Prevalence of Zoonotic Diseases
The growing incidence of zoonotic diseases is a significant driver of the Veterinary Antimicrobial Susceptibility Market. As zoonotic infections, which can transfer from animals to humans, become more common, the need for effective antimicrobial treatments increases. Veterinary antimicrobial susceptibility testing plays a crucial role in identifying resistant pathogens, helping to develop precise treatment strategies for infected animals and preventing the spread of infections to humans. This heightened awareness of zoonotic risks contributes directly to the market’s expansion.
For instance, Zoetis has been actively monitoring antimicrobial resistance for over 25 years through its surveillance program, which studies 29 different bacterial pathogens across five animal species in collaboration with 32 veterinary diagnostic laboratories.
Increasing Demand for High-Quality Animal-Based Products
The demand for high-quality animal-based products continues to grow globally, which drives the need for effective veterinary care. Consumers increasingly seek products from healthy animals, particularly in the food industry. Veterinary antimicrobial susceptibility testing ensures the health of animals by guiding appropriate antimicrobial treatments, thus maintaining the quality of animal-derived products. The growing consumer concern over food safety and animal health further fuels this market demand.
For instance, using genetic ranking tools from Zoetis like CLARIFIDE Plus, it was found that dairy cows with lower genetic resistance to mastitis required 3 times more intramammary antibiotics than cows with the best genetic resistance.
Advancements in Veterinary Diagnostics
Continuous advancements in veterinary diagnostics are positively impacting the Veterinary Antimicrobial Susceptibility Market. The development of rapid diagnostic tools enables faster and more accurate identification of antimicrobial resistance in animals. These innovations are crucial for reducing the use of ineffective antibiotics and preventing the emergence of further resistance. As veterinary diagnostics evolve, more reliable solutions are becoming available, improving both animal health and public safety.
Focus on Preventive Measures in Veterinary Care
The increasing focus on preventive measures in veterinary care contributes to the expansion of the Veterinary Antimicrobial Susceptibility Market. Preventive strategies, such as vaccination and early identification of antimicrobial resistance, help reduce the need for reactive treatments. Testing for antimicrobial susceptibility is essential in this proactive approach, enabling veterinarians to prevent infections before they spread, reducing overall treatment costs and enhancing animal welfare. This shift toward prevention is reshaping veterinary practices and boosting market demand.
Market Trends:
Expansion of Point-of-Care Diagnostic Solutions
The Veterinary Antimicrobial Susceptibility Market is experiencing a significant trend toward the expansion of point-of-care diagnostic solutions. These technologies enable veterinarians to conduct rapid antimicrobial susceptibility testing directly in the field or clinic, reducing the need for laboratory-based diagnostics. The convenience and speed of these tests allow for faster decision-making, which is crucial in managing infectious diseases in animals. By providing real-time results, point-of-care solutions help mitigate the spread of resistant pathogens. Veterinary professionals increasingly rely on these tests for more precise treatment regimens, leading to more effective antimicrobial use. This trend supports the growing need for antimicrobial stewardship and is expected to continue driving market growth.
For instance, Bioguard Corporation’s miniAST, a veterinary antibiotic susceptibility test analyzer, delivers results in just 8 hours, enabling swift and confident treatment decisions.
Rise in Regulatory Standards and Global Initiatives
Another prominent trend in the Veterinary Antimicrobial Susceptibility Market is the rise in regulatory standards and global initiatives focused on combating antimicrobial resistance (AMR). Governments and international organizations, such as the World Health Organization (WHO), are placing greater emphasis on regulating antibiotic use in veterinary practices. These regulations promote the responsible use of antibiotics and encourage the adoption of antimicrobial susceptibility testing as part of routine veterinary care. Stricter regulations are helping to foster a more sustainable approach to animal health, ensuring that antibiotics are used appropriately to prevent the development of resistance. With ongoing efforts to implement and enforce these standards, the market is expected to see continued growth in demand for antimicrobial testing solutions.
For instance, in a recent report, the World Organisation for Animal Health (WOAH) highlighted that 157 countries submitted data on antimicrobial use in animals as part of its global monitoring initiative.
Market Challenges Analysis:
High Costs of Diagnostic Technologies
One of the major challenges faced by the Veterinary Antimicrobial Susceptibility Market is the high cost of diagnostic technologies. The advanced equipment required for antimicrobial susceptibility testing often comes with a significant price tag, making it difficult for smaller veterinary practices, especially in developing regions, to afford these solutions. The initial investment and ongoing maintenance costs can be prohibitive, limiting widespread adoption of these technologies. This financial barrier restricts access to rapid and accurate diagnostic tools that could help improve animal health outcomes. Cost-effective solutions that maintain diagnostic accuracy are crucial to overcoming this challenge and ensuring broader market adoption.
Lack of Standardization in Testing Protocols
The lack of standardization in testing protocols also poses a challenge to the Veterinary Antimicrobial Susceptibility Market. Variations in testing methods and the absence of uniform guidelines for antimicrobial susceptibility testing can lead to inconsistent results, which may affect treatment decisions. Discrepancies in protocols across different regions and veterinary practices create uncertainty, making it difficult to compare data or ensure reliable treatment outcomes. Establishing standardized protocols for antimicrobial susceptibility testing is essential for improving the overall effectiveness of veterinary care and fostering greater confidence in the results. This challenge needs to be addressed to fully harness the potential of susceptibility testing in combating antimicrobial resistance.
Market Opportunities:
Increasing Adoption of Antimicrobial Stewardship Programs
One of the key opportunities for the Veterinary Antimicrobial Susceptibility Market lies in the increasing adoption of antimicrobial stewardship programs. These programs promote the responsible use of antibiotics in veterinary care, driving demand for antimicrobial susceptibility testing to ensure antibiotics are only prescribed when necessary. As governments and regulatory bodies enforce stricter antimicrobial usage guidelines, veterinary professionals are more inclined to adopt these stewardship programs. This trend creates a growing need for reliable and rapid diagnostic tools, providing significant market potential for companies that offer advanced antimicrobial testing solutions. The expansion of such programs is likely to further increase the uptake of veterinary antimicrobial susceptibility testing.
Growing Investment in Veterinary Health Infrastructure
Another opportunity for the Veterinary Antimicrobial Susceptibility Market is the growing investment in veterinary health infrastructure, particularly in emerging markets. Increasing urbanization, rising disposable incomes, and improved healthcare systems in regions such as Asia-Pacific present opportunities for market expansion. As more veterinary clinics and hospitals are equipped with modern diagnostic facilities, the demand for antimicrobial susceptibility testing will increase. Investments in animal health infrastructure, along with rising awareness about antimicrobial resistance, will drive the market’s growth, creating opportunities for technological advancements and the development of cost-effective diagnostic tools to meet the needs of the veterinary sector.
Market Segmentation Analysis:
By Product
The Veterinary Antimicrobial Susceptibility Market is segmented by product into antimicrobial susceptibility testing kits and instruments. The kits segment holds a significant share due to the increasing demand for rapid and accurate testing solutions in veterinary care. These kits enable faster diagnosis of antimicrobial resistance in animals, aiding in better treatment decisions. Instruments used in susceptibility testing, such as automated systems and microbiology analyzers, also contribute to market growth by enhancing diagnostic accuracy and throughput.
For instance, HORIBA’s POCKIT™ Central system, an automated veterinary PCR analyzer, can deliver accurate results for up to 8 pathogens in a single run in just 85 minutes.
By Animal Type
The market is further segmented by animal type, including companion animals, livestock, and others. The livestock segment holds the largest market share, driven by the large populations of animals requiring health management, particularly in the food production industry. Companion animals, especially dogs and cats, are also seeing increased demand for antimicrobial susceptibility testing due to the growing pet care industry. The segment for other animals, such as horses and exotic animals, is expected to witness steady growth due to rising concerns about animal welfare.
For instance, highlighting the large scale of testing in the livestock sector, Cornell University’s Quality Milk Production Services tests over 300,000 cows each year.
By End-Use
The end-use segment includes veterinary hospitals, clinics, diagnostic laboratories, and research institutions. Veterinary hospitals and clinics dominate the market, as they are the primary centers for diagnosing and treating infectious diseases in animals. Diagnostic laboratories play a key role in providing specialized testing services. Research institutions contribute to market growth by driving innovations in antimicrobial susceptibility testing methods and tools, supporting the development of more effective treatments and diagnostics.
North America: Market Leadership and Regulatory Advancements
North America holds 40% of the Veterinary Antimicrobial Susceptibility Market share, driven by its advanced healthcare infrastructure, robust regulatory frameworks, and growing awareness of antimicrobial resistance (AMR). The region’s stringent regulations on antibiotic use in veterinary practices have accelerated the adoption of antimicrobial susceptibility testing. The United States, in particular, has been a pioneer in antimicrobial stewardship programs and is actively working towards reducing antibiotic resistance in both human and animal health. The growing demand for high-quality animal-based products and improved veterinary care further boosts market growth in this region, making it a dominant player in the global market.
Europe: Stringent Regulations and Growing Awareness
Europe commands 30% of the Veterinary Antimicrobial Susceptibility Market share, driven by stringent regulatory measures and heightened public health awareness. The European Union has implemented comprehensive regulations governing antimicrobial use in animals, which encourages veterinary practices to adopt responsible treatment protocols. The region’s ongoing efforts to combat AMR through policy reforms and investment in veterinary diagnostics create favorable conditions for market expansion. European countries are focusing on improving veterinary care standards and ensuring sustainable antimicrobial usage, which drives demand for susceptibility testing solutions. The recognition of the importance of these tests continues to expand the European market.
Asia-Pacific: Rapid Growth and Emerging Opportunities
The Asia-Pacific region holds 20% of the Veterinary Antimicrobial Susceptibility Market share, driven by increasing livestock populations, rapidly growing economies, and the improving veterinary care infrastructure in countries like China and India. The region’s rising focus on combating AMR and growing awareness about animal health contribute to market growth. As demand for animal-based products continues to rise and modern veterinary practices are adopted, the need for antimicrobial susceptibility testing will grow. This combination of factors positions the Asia-Pacific region for rapid market expansion in the coming years.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
The Veterinary Antimicrobial Susceptibility Market is highly competitive, with key players striving to develop advanced solutions for antimicrobial resistance in animals. Leading companies in the market include bioMérieux, Thermo Fisher Scientific, and BD. These players focus on providing reliable and rapid diagnostic tools to enhance veterinary care and prevent the spread of resistant pathogens. The market sees intense competition driven by innovations in diagnostic technologies and the growing need for faster, more accurate testing solutions. Companies are investing in research and development to offer comprehensive testing kits and automated systems that streamline veterinary diagnostics. Regional players also contribute to the competitive landscape by offering cost-effective solutions and catering to the growing veterinary needs in emerging markets. Strong regulatory frameworks and increasing awareness about antimicrobial resistance push companies to improve the effectiveness and accessibility of their products, thereby shaping the competitive dynamics of the market.
Recent Developments:
In August 2025, BioMérieux launched GENE-UP® PRO HRM, a DNA-based test for detecting heat-resistant molds.
In February 2025, BioMérieux launched GENE-UP® TYPER, a diagnostic solution for the food industry to identify the source of Listeria monocytogenes contamination.
In May 2025, Danaher Corporation initiated a partnership with AstraZeneca to develop and commercialize new diagnostic tools aimed at advancing precision medicine.
Market Concentration & Characteristics:
The Veterinary Antimicrobial Susceptibility Market is moderately concentrated, with a few key players dominating the market, such as bioMérieux, Thermo Fisher Scientific, and BD. These companies lead the market by offering a range of advanced diagnostic tools, including antimicrobial susceptibility testing kits and automated systems. The market is characterized by high innovation, with constant advancements in diagnostic technologies aimed at providing faster, more accurate results. Regulatory frameworks and increasing awareness of antimicrobial resistance push companies to enhance the efficiency of their products. Smaller players also contribute to the market by offering cost-effective solutions tailored to regional veterinary needs. The competitive environment is driven by ongoing research and development, strategic collaborations, and the growing focus on improving animal health through effective antimicrobial stewardship.
Report Coverage:
The research report offers an in-depth analysis based on Product, Animal Type, End-Use and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook:
The Veterinary Antimicrobial Susceptibility Market will continue to grow as antimicrobial resistance in animals remains a significant global concern.
Ongoing advancements in diagnostic technologies will drive the development of more accurate and rapid susceptibility testing tools.
Increased regulatory pressure on antimicrobial use in veterinary care will fuel demand for efficient susceptibility testing solutions.
The rising adoption of antimicrobial stewardship programs will further promote the use of susceptibility testing to optimize antibiotic use.
The growing focus on preventive veterinary care will lead to more widespread use of antimicrobial susceptibility testing in early disease detection.
Innovations in point-of-care diagnostic solutions will enhance accessibility to susceptibility testing in remote and underserved regions.
Emerging markets in Asia-Pacific and Latin America will see rapid growth due to improving veterinary infrastructure and rising animal health awareness.
Strategic partnerships and collaborations between industry leaders and research institutions will drive product innovations and expand market reach.
Increased investments in veterinary research and development will lead to the introduction of more affordable and effective diagnostic solutions.
Rising consumer demand for high-quality, safe animal-based products will further support the market’s expansion, promoting healthier livestock and companion animals.
For Table OF Content – Request For Sample Report –
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Request Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Frequently Asked Questions
What is the current market size for Veterinary Antimicrobial Susceptibility, and what is its projected size in 2032?
The Veterinary Antimicrobial Susceptibility Market was valued at USD 1,019 million in 2024 and is expected to reach USD 1,553.2 million by 2032.
At what Compound Annual Growth Rate is the Veterinary Antimicrobial Susceptibility market projected to grow between 2024 and 2032?
The market is projected to grow at a CAGR of 5.41% during the forecast period from 2024 to 2032.
Which Veterinary Antimicrobial Susceptibility market segment held the largest share in 2024?
In 2024, the antimicrobial susceptibility testing kits segment held the largest share of the market.
What are the primary factors fueling the growth of the Veterinary Antimicrobial Susceptibility market?
The key drivers include the rising prevalence of zoonotic diseases, increasing demand for high-quality animal-based products, advancements in veterinary diagnostics, and the growing adoption of rapid diagnostic tests.
Who are the leading companies in the Veterinary Antimicrobial Susceptibility market?
Leading companies in the market include bioMérieux, Thermo Fisher Scientific, and BD, which offer advanced diagnostic tools for antimicrobial susceptibility testing.
Which region commanded the largest share of the Veterinary Antimicrobial Susceptibility market in 2024?
North America commanded the largest share of the Veterinary Antimicrobial Susceptibility market in 2024, driven by advanced healthcare infrastructure and strong regulatory frameworks.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$4699
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$5699
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.
